Getinge iCast covered stent system considered medically necessary for treatment of iliac arterial occlusive disease
Today, Getinge announced Aetna, a leading health insurance benefits company in the United States, issued a Clinical Policy Bulletin (CPB) addressing peripheral vascular stents. Aetna issued a revised CPB stating that the iCast covered stent system is considered medically necessary for the treatment of iliac arterial occlusive disease. The insurance provider previously designated the medical device as experimental and investigational. The determination was based upon review in March 2024 of currently available clinical information, according to the CPB, including clinical